The effect of bowel resection on survival in advanced epithelial ovarian cancer

被引:63
作者
Jaeger, W
Ackermann, S
Kessler, H
Katalinic, A
Lang, N
机构
[1] Univ Erlangen Nurnberg, Frauenklin, Dept Obstet & Gynecol, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Surg, D-91054 Erlangen, Germany
[3] Univ Luebeck, Inst Canc Epidemiol, Lubeck, Germany
关键词
ovarian cancer; surgical treatment; bowel metastases; bowel resection;
D O I
10.1006/gyno.2001.6375
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. FIGO stage III ovarian cancer is further categorized according to the size of tumor, but not according to the organs affected. In this study we evaluated the outcome of patients with and without macroscopic bowel involvement in stage III ovarian cancer. Methods. This retrospective study analyzed the outcome of 194 ovarian cancer patients with FIGO III with and without bowel involvement who were operated on in our institution between 1985 and 1994. Results. The study demonstrated that maximum tumor reduction without remaining macroscopic cancer offered the best overall survival times in FIGO III ovarian cancer patients. However, whenever the bowel was involved, even maximum bowel resections did not prolong survival compared to patients with remaining tumor after surgery. Conclusions. This retrospective study demonstrated that bowel involvement in ovarian cancer had a bad prognosis and that survival in these patients could not substantially be prolonged when the affected parts of bowel were resected. To further substantiate these findings, future studies on advanced ovarian cancer should differentiate between patients with and without bowel involvement. (C) 2001 Academic Press.
引用
收藏
页码:286 / 291
页数:6
相关论文
共 50 条
  • [41] The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer
    Hakan Karagol
    Pinar Saip
    Kazim Uygun
    Murat Caloglu
    Yesim Eralp
    Faruk Tas
    Adnan Aydiner
    Erkan Topuz
    Medical Oncology, 2007, 24 : 39 - 43
  • [42] The survival detriment of venous thromboembolism with epithelial ovarian cancer
    Gunderson, Camille C.
    Thomas, Eric D.
    Slaughter, Katrina N.
    Farrell, Regina
    Ding, Kai
    Farris, Ronni E.
    Lauer, Jacob K.
    Perry, LaToya J.
    McMeekin, D. Scott
    Moore, Kathleen N.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (01) : 73 - 77
  • [43] TAMOXIFEN IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER
    VANDERVELDEN, J
    GITSCH, G
    WAIN, GV
    FRIEDLANDER, ML
    HACKER, NF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (04) : 301 - 305
  • [44] Management of retroperitoneal lymphadenectomy in advanced epithelial ovarian cancer
    Jaffre, I.
    Bordes, V.
    Dejode, M.
    Dravet, F.
    Classe, J. -M.
    BULLETIN DU CANCER, 2010, 97 (01) : 65 - 71
  • [45] Cytoreductive surgery in primary advanced epithelial ovarian cancer
    Luca Ansaloni
    Federico Coccolini
    Fausto Catena
    Luigi Frigerio
    Robert E Bristow
    World Journal of Obstetrics and Gynecology, 2013, (04) : 116 - 123
  • [46] First line chemotherapy of advanced epithelial ovarian cancer
    Lhomme, C.
    Even, C.
    Morice, P.
    Balleyguier, C.
    Petrella, M. C.
    Gouy, S.
    Uzan, C.
    Duvillard, P.
    Pautier, P.
    BULLETIN DU CANCER, 2009, 96 (12) : 1207 - 1213
  • [47] Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Martinez, A.
    Pomel, C.
    Mery, E.
    Querleu, D.
    Gladieff, L.
    Ferron, G.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (02) : 258 - 263
  • [48] Effect of topotecan on serum CA-125 in patients with advanced epithelial ovarian cancer
    Nielsen, HA
    Nielsen, D
    Engelholm, SA
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 383 - 388
  • [49] Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer
    Chambers, Laura M.
    Kuznicki, Michelle
    Yao, Meng
    Chichura, Anna
    Gruner, Morgan
    Reizes, Ofer
    Debernardo, Robert
    Rose, Peter G.
    Michener, Chad
    Vargas, Roberto
    GYNECOLOGIC ONCOLOGY, 2020, 159 (03) : 699 - 705
  • [50] Comparison of Survival Outcomes Based on Pre-treatment Pleural Effusion in Advanced Epithelial Ovarian Cancer
    Lee, Juhun
    Hong, Dae Gy
    ANTICANCER RESEARCH, 2022, 42 (10) : 4937 - 4943